File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Biodistribution, pharmacokinetics and toxicology of Ag2S near-infrared quantum dots in mice

TitleBiodistribution, pharmacokinetics and toxicology of Ag<inf>2</inf>S near-infrared quantum dots in mice
Authors
KeywordsAg S quantum dots 2
Biocompatibility
Biodistribution
Pharmacokinetics
Toxicology
Issue Date2013
Citation
Biomaterials, 2013, v. 34, n. 14, p. 3639-3646 How to Cite?
AbstractAg2S quantum dots (QDs) have been demonstrated as a promising near-infrared II (NIR-II, 1.0-1.4 μm) emitting nanoprobe for in vivo imaging and detection. In this work, we carefully study the long-term in vivo biodistribution of Ag2S QDs functionalized with polyethylene glycol (PEG) and systematically examine the potential toxicity of Ag2S QDs over time. Our results show that PEGylated-Ag2S QDs are mainly accumulated in the reticuloendothelial system (RES) including liver and spleen after intravenous administration and can be gradually cleared, mostly by fecal excretion. PEGylated-Ag2S QDs do not cause appreciable toxicity at our tested doses (15 and 30 mg/kg) to the treated mice over a period of 2 months as evidenced by blood biochemistry, hematological analysis and histological examinations. Our work lays a solid foundation for further biomedical applications of Ag2S QDs as an important in vivo imaging agent in the NIR-II region. © 2013 Elsevier Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/334313
ISSN
2023 Impact Factor: 12.8
2023 SCImago Journal Rankings: 3.016
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZhang, Yan-
dc.contributor.authorZhang, Yejun-
dc.contributor.authorHong, Guosong-
dc.contributor.authorHe, Wei-
dc.contributor.authorZhou, Kun-
dc.contributor.authorYang, Kai-
dc.contributor.authorLi, Feng-
dc.contributor.authorChen, Guangcun-
dc.contributor.authorLiu, Zhuang-
dc.contributor.authorDai, Hongjie-
dc.contributor.authorWang, Qiangbin-
dc.date.accessioned2023-10-20T06:47:14Z-
dc.date.available2023-10-20T06:47:14Z-
dc.date.issued2013-
dc.identifier.citationBiomaterials, 2013, v. 34, n. 14, p. 3639-3646-
dc.identifier.issn0142-9612-
dc.identifier.urihttp://hdl.handle.net/10722/334313-
dc.description.abstractAg2S quantum dots (QDs) have been demonstrated as a promising near-infrared II (NIR-II, 1.0-1.4 μm) emitting nanoprobe for in vivo imaging and detection. In this work, we carefully study the long-term in vivo biodistribution of Ag2S QDs functionalized with polyethylene glycol (PEG) and systematically examine the potential toxicity of Ag2S QDs over time. Our results show that PEGylated-Ag2S QDs are mainly accumulated in the reticuloendothelial system (RES) including liver and spleen after intravenous administration and can be gradually cleared, mostly by fecal excretion. PEGylated-Ag2S QDs do not cause appreciable toxicity at our tested doses (15 and 30 mg/kg) to the treated mice over a period of 2 months as evidenced by blood biochemistry, hematological analysis and histological examinations. Our work lays a solid foundation for further biomedical applications of Ag2S QDs as an important in vivo imaging agent in the NIR-II region. © 2013 Elsevier Ltd.-
dc.languageeng-
dc.relation.ispartofBiomaterials-
dc.subjectAg S quantum dots 2-
dc.subjectBiocompatibility-
dc.subjectBiodistribution-
dc.subjectPharmacokinetics-
dc.subjectToxicology-
dc.titleBiodistribution, pharmacokinetics and toxicology of Ag<inf>2</inf>S near-infrared quantum dots in mice-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.biomaterials.2013.01.089-
dc.identifier.pmid23415643-
dc.identifier.scopuseid_2-s2.0-84875254244-
dc.identifier.volume34-
dc.identifier.issue14-
dc.identifier.spage3639-
dc.identifier.epage3646-
dc.identifier.eissn1878-5905-
dc.identifier.isiWOS:000317534200010-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats